Ioptima Overview

  • Founded

  • 2002

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 12

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $23M

Ioptima General Information

Description

Manufacturer of minimally-invasive surgical ophthalmic devices created to offer laser technology for the treatment of Glaucoma. The company's minimally-invasive surgical ophthalmic devices include IOPtimatea CO2 Laser-Assisted Sclerectomy Surgery (CLASS) surgical system used to address the unmet needs and common safety problems in glaucoma surgery, enabling surgeons achieve functional, simple, safe, reproducible and optimal results from surgery, with minimal side effects and reduced recovery time.

Contact Information

Website
www.ioptima.co.il
Formerly Known As
OptoTech
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Parent Company
Chengdu Kanghong Pharmaceutical
Primary Office
  • Building 3, 5th Floor
  • Kiryat Atidim
  • Tel Aviv 6158101
  • Israel
+972 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ioptima Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 21-Nov-2017 $23M 00.00 0000 Completed Generating Revenue
3. Later Stage VC 25-Nov-2015 00.00 00.00 000.00 Completed Generating Revenue
2. Angel (individual) Completed Generating Revenue
1. Merger/Acquisition Completed Generating Revenue
To view Ioptima’s complete valuation and funding history, request access »

Ioptima Patents

  • 23

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Ioptima Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3893824-A4 Methods and systems for laser assisted technology for minimally-invasive ab-interno glaucoma surgery Pending 13-Dec-2018 00000000000 0
EP-3893824-A2 Methods and systems for laser assisted technology for minimally-invasive ab-interno glaucoma surgery Pending 13-Dec-2018 00000000000
US-20220047422-A1 Methods and systems for laser assisted technology for minimally-invasive ab-interno glaucoma surgery Pending 13-Dec-2018 00000000000
EP-3636230-A1 Device for performing surgical manipulation of the sclera Inactive 12-Oct-2018 00000000000 0
US-20200113735-A1 Device for performing surgical manipulation of the sclera Inactive 12-Oct-2018 A61F9/00781
To view Ioptima’s complete patent history, request access »

Ioptima Executive Team (4)

Name Title Board Seat Contact Info
Ronen Castro Chief Executive Officer
Itai Bar-Natan Chief Financial Officer
Amnon Nahum-Sharon Chief Operating Officer & Director, Quality Assurance/Regulatory Affairs
You’re viewing 3 of 4 executive team members. Get the full list »

Ioptima Board Members (4)

Name Representing Role Since
Doron Birger Self Chairman 000 0000
Eli Shohet Ioptima Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Ioptima Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ioptima Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioLight Life Sciences Venture Capital Majority 000 0000 000000 0
Diamond Capital (Taiwan) Venture Capital Minority 000 0000 000000 0
Infinity Group Venture Capital Minority 000 0000 000000 0
To view Ioptima’s complete investors history, request access »

Ready to get started?

Request a free trial